Lucia Aronica
Lucia Aronica has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Volkov
Bennet Data Sciences, San Diego, CA 92107, USA
1 shared publication - Brent Eck
Department of Nutrition Science, Metagenics, Inc., Aliso Viejo, CA 92656, USA
1 shared publication - Deanna M. Minich
Institute for Functional Medicine, Federal Way, WA 98003, USA
1 shared publication - Dina Metti
Personalized Lifestyle Medicine Center, Gig Harbor, WA 98332, USA
1 shared publication - Ilona A. Larson
Department of Nutrition Science, Metagenics, Inc., Aliso Viejo, CA 92656, USA
1 shared publication - Jeffrey S. Bland
Personalized Lifestyle Medicine Institute, Bainbridge Island, WA 98110, USA
1 shared publication
Latest Publications
- Open Access
Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine
Metabolic detoxification (detox)—or biotransformation—is a physiological function that removes toxic substances from our body. Genetic variability and dietary factors may affect the function of detox enzymes, thus impacting the body’s sensitivity to toxic substances of endogenous and exogenous origin. From a genetic perspective, most of the current knowledge relies on observational studies in humans or experimental models in vivo and in vitro, with very limited proof of causality and clinical value. This review provides health practitioners with a list of single nucleotide polymorphisms (SNPs) located within genes involved in Phase I and Phase II detoxification reactions, for which evidence of clinical utility does exist. We have selected these SNPs based on their association with interindividual variability of detox metabolism in response to certain nutrients in the context of human clinical trials. In order to facilitate clinical interpretation and usage of these SNPs, we provide, for each of them, a strength of evidence score based on recent guidelines for genotype-based dietary advice. We also present the association of these SNPs with functional biomarkers of detox metabolism in a pragmatic clinical trial, the LIFEHOUSE study.
Open AccessGenetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine
Metabolic detoxification (detox)—or biotransformation—is a physiological function that removes toxic substances from our body. Genetic variability and dietary factors may affect the function of detox enzymes, thus impacting the body’s sensitivity to toxic substances of endogenous and exogenous origin. From a genetic perspective, most of the current knowledge relies on observational studies in humans or experimental models in vivo and in vitro, with very limited proof of causality and clinical value. This review provides health practitioners with a list of single nucleotide polymorphisms (SNPs) located within genes involved in Phase I and Phase II detoxification reactions, for which evidence of clinical utility does exist. We have selected these SNPs based on their association with interindividual variability of detox metabolism in response to certain nutrients in the context of human clinical trials. In order to facilitate clinical interpretation and usage of these SNPs, we provide, for each of them, a strength of evidence score based on recent guidelines for genotype-based dietary advice. We also present the association of these SNPs with functional biomarkers of detox metabolism in a pragmatic clinical trial, the LIFEHOUSE study.